Over the last decade, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become integral in the management of T2D owing to their capacity to improve glycemic control, promote weight loss, and reduce the incidence of major adverse cardiovascular events (MACE)
Thus, in overweight/obese women with PCOS, combination treatment is more effective than metformin alone by improving insulin sensitivity, with tolerable short-term side effects (201)
Normally, we need about 15 days for production
Despite their good properties and high drug-coupling capacity poly(l-glutamic acid) nanosystems have been rarely investigated for brain drug delivery [23, 24]
While there are evidence-based protocols in place, the day-to-day execution is highly individualized - including dietary preferences, exercise capacity, and communication style